Skip to content

CONNECTING PHARMA

Active
Private limited companyfounded 2012active for 14 yearsEdmond Boonenstraat 4, 9000 Ghent, BelgiumKBO/BCE: BE 0846.826.628

Deeds, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
25-06
NBB filing Annual accounts 2025 filedNBB
micro format · 36 days before the deadline
2025
11-06
NBB filing Annual accounts 2024 filedPDF
micro format · 50 days before the deadline
2024
11-06
NBB filing Annual accounts 2023 filedPDF
micro format · 50 days before the deadline
2023
14-06
Gazette deed Merger: ASCLEPIA OUTSOURCING SOLUTIONS takes over CONNECTING PHARMA
Company renamed from ASCLEPIA OUTSCOURCING SOLUTIONS to CONNECTING PHARMA · Change of role: DEROOS Frederik Dirk, from director to statutory director · Reappointment: DERO0SE Frederik Dirk (statutory director)12 points ▸
  • General meeting, 30-05-2023, mentioned twice in the deed
  • The company holds all the shares of CONNECTING PHARMA
  • Accounting effect, 01-04-2023
  • Real estate, CONNECTING PHARMA
  • Director resignation, DEROOS Frederik Dirk
  • Director discharge, DEROOS Frederik Dirk
  • Name change, CONNECTING PHARMA
  • 186 shares
  • Director appointment, DEROOS Frederik Dirk (statutory director)
  • Power of attorney, Frits GUISSON
  • Director reappointment, DERO0SE Frederik Dirk (statutory director)
  • Director discharge, DERO0SE Frederik Dirk (manager)
  • The deed holds 25 more points.

Open the deed in the Belgian Official Gazette

25-04
Gazette deed Merger proposal: Asclepia Outsourcing Solutions takes over Connecting Pharma BV
The company holds 100 shares of Connecting Pharma BV · Frederik Deroose holds 186 shares8 points ▸
  • Incorporation, 30-09-2021
  • 100 shares
  • The company holds 100 shares of Connecting Pharma BV
  • Board composition, Frederik Deroose (director), mentioned twice in the deed
  • Accounting effect, 01-04-2023, mentioned twice in the deed
  • Incorporation, 20-06-2012
  • 186 shares
  • Frederik Deroose holds 186 shares
  • The deed holds 8 more points.

Open the deed in the Belgian Official Gazette

2022
29-11
NBB filing Annual accounts 2022 filedPDF
micro format · 32 days before the deadline
2021
17-12
NBB filing Annual accounts 2021 filedPDF
micro format · 14 days before the deadline
31-05
Financial Weakest financial yearnet €24,401 ▼64.7%
The net result drops to €24,401, the lowest from 2019 to 2025. It recovers the following year.
2020
18-12
NBB filing Annual accounts 2020 filedPDF
micro format · 13 days before the deadline
31-05
Financial Highest result from 2019 to 2025net €69,174 ▲99.3%
The operating result of €92,842 and the net result of €69,174 are both a record.
31-05
Financial Liquidity more than doubledcurrent ratio 5.05
The current ratio rises from 2.25 to 5.05. Short-term debt falls from €143,720 to €69,030.
31-05
Financial Equity above €200,000equity €230,173 ▲25.8%
With a profit in every financial year since 2019, equity grows to €230,173.
Show earlier events
31-01
NBB filing Annual accounts 2019 filedPDF
micro format · 31 days late
2018
17-12
NBB filing Annual accounts 2018 filedPDF
micro format · 14 days before the deadline
2017
15-12
NBB filing Annual accounts 2017 filedPDF
micro format · 16 days before the deadline
2016
08-12
NBB filing Annual accounts 2016 filedPDF
abbreviated format · 23 days before the deadline
2012
04-07
Gazette deed IncorporationPDF
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

On 20 June 2012, CONNECTING PHARMA was incorporated.1 CONNECTING PHARMA was merged into the company in 2023.2 Total assets went from €513,119 in 2023 to €312,342 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 14-06-2023
  3. 3National Bank, annual accounts 2023 and 2025

Next steps